The Patent Finder

Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)

Pharmacyclics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 13 of these applications claim priority to application 13/153,317, filed Jun 3, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,754,090Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 8,999,999Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 9,125,889Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 9,801,881Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 9,801,883Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 9,814,721Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · High confidence
Pharmacyclics LLCIn force
High confidence
US 10,004,745Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 10,004,746Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
US 10,016,435Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · High confidence
Pharmacyclics LLCIn force
High confidence
US 10,478,439Use of Inhibitors of Bruton's Tyrosine Kinase (BTK)
In force
 · Medium confidence
Pharmacyclics LLCIn force
Medium confidence
15 more patents in this group · Pro
10 of 25 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 25.
Upgrade to Pro
13 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited